JACK CRIBB: Open Payments
NPI 1497961635 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,896 in 93 payments from 17 companies in 2025. Trend: 2023 $1,643 · 2024 $1,258 · 2025 $1,896
Food & beverage: $1,896
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 18 | $458 |
| Novo Nordisk Inc | 20 | $397 |
| PFIZER INC. | 10 | $196 |
| AstraZeneca Pharmaceuticals LP | 9 | $173 |
| Axsome Therapeutics, Inc. | 8 | $140 |
| Viatris Specialty LLC | 4 | $91 |
| Lilly USA, LLC | 5 | $87 |
| ABBVIE INC. | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
Products named: Leqembi, Ozempic, Rybelsus, Auvelity, BREZTRI, ZAVZPRET, NURTEC ODT, YUPELRI.
Industry payments across MI — which companies pay providers there.
